Solicited Testimony from Authorities in the Field Regarding the Current HIV Vaccine Effort, in the United States and Internationally

Given our prior experience with face-to-face interviews about microbicides on 7 December,
and a conference-call interview with one guest researcher on pediatric research on 15 March, this
multi-guest format remains a bit of an experiment, and I hope all will bear with the need for
brevity, directness, and strictness with the time allocations. If they wish, the guest experts are
invited to fax advance brief written statements to the Research Committee members providing
relevant biodata on themselves (to supplement the limited information I have provided in the
schedule below), plus explanation, supplementation, or background for their verbal assessments
and/or advocacy proposals.
Below please find a schedule for the 1-1/2 hour session. Each guest expert is allocated 5
minutes for a statement and 5 minutes for questions from the Committee members. Guest
experts are welcome to listen to the entire call and -- when Committee members have no more
questions to ask -- to participate in the questions, answers, and discussion.
BECAUSE AT&T CONFERENCE-CALL PORTS ARE LIMITED, GUESTS ARE
REQUESTED TO USE ONLY ONE INCOMING PHONE LINE TO CONNECT TO THE
SESSION AND NOT TO DIVULGE THE 800 NUMBER AND CODE. However, others at
their location may listen to the call using handset extensions or a speaker phone on the same
telephone circuit.
SCHEDULE (All times Eastern Standard)

9:30 - 9:35
9:35 - 9:45
9:45 - 9:55

Committee Housekeeping; Announcements
Dani Bolognesi, PhD
Professor and Director, Center for AIDS Research, Duke University;
Co-Director, Human Vaccine Institute. Prominent researcher in HIV
biology, HIV vaccines, and HIV immune reconstitution; principal of
Central Immunology Laboratory for AIDS Vaccine Clinical Trials; Chair
of Vaccine R&D; Area Review Panel of the OAR evaluation committee.
Current/past member: NIH AIDS Vaccine Selection Committee, NIH
AIDS Vaccine Working Group, WHO Vaccine Steering Committee.
Mary-Lou Clements, MD, MPH
Professor, Johns Hopkins University Center for Immunization Research;
principal investigator in NIH AIDS Vaccine Evaluation Unit network;
extensive experience in clinical R & D of vaccines for other human
diseases; current/past member: WHO steering committee for HIV vaccine
development, CDC Advisory Committee on Immunization Practices,
Institute of Medicine Committee on Children's Vaccine Initiative.

9:55 - 10:05 Jose Esparza, MD, PhD
Chief of HIV vaccine development, Global Program on AIDS, WHO &
UNAIDS. Virologist and epidemiologist facilitating and coordinating
AIDS vaccine research and development issues on international level since
1987.